-
1
-
-
0000517779
-
Principles and applications of biologic therapy
-
edited by VT DeVita Jr, S Hellman, SA Rosenberg, Philadelphia, JB Lippincott
-
Rosenberg SA, Longo DL, Lotze MT: Principles and applications of biologic therapy. In: Cancer-Principles and Practice of Oncology, Vol III, edited by VT DeVita Jr, S Hellman, SA Rosenberg, Philadelphia, JB Lippincott, 1989, pp 301-437.
-
(1989)
Cancer-Principles and Practice of Oncology
, vol.3
, pp. 301-437
-
-
Rosenberg, S.A.1
Longo, D.L.2
Lotze, M.T.3
-
2
-
-
0026425647
-
Immunotherapy and gene therapy of cancer
-
Rosenberg SA: Immunotherapy and gene therapy of cancer. Cancer Res 51(Suppl):5074s-5079s, 1991.
-
(1991)
Cancer Res
, vol.51
, Issue.SUPPL.
-
-
Rosenberg, S.A.1
-
3
-
-
0028127956
-
New directions in molecular medicine
-
Karp JE, Broder S: New directions in molecular medicine. Cancer Res 54:653-665, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 653-665
-
-
Karp, J.E.1
Broder, S.2
-
5
-
-
0026718123
-
Human gene therapy comes of age
-
Miller AD: Human gene therapy comes of age. Nature 356:455-460, 1992.
-
(1992)
Nature
, vol.356
, pp. 455-460
-
-
Miller, A.D.1
-
6
-
-
0026060779
-
Delivery systems for gene therapy
-
Wu GY, Wu CH: Delivery systems for gene therapy. Biotherapy 3:87-95, 1991.
-
(1991)
Biotherapy
, vol.3
, pp. 87-95
-
-
Wu, G.Y.1
Wu, C.H.2
-
7
-
-
0023767556
-
Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo
-
Guild BC, Finer MH, Housman DE, et al: Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. J Virol 62: 3795-3801, 1988.
-
(1988)
J Virol
, vol.62
, pp. 3795-3801
-
-
Guild, B.C.1
Finer, M.H.2
Housman, D.E.3
-
8
-
-
0024584811
-
High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors
-
Zwiebel JA, Freeman SM, Kantoff PW, et al: High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors. Science 243:220-222, 1989.
-
(1989)
Science
, vol.243
, pp. 220-222
-
-
Zwiebel, J.A.1
Freeman, S.M.2
Kantoff, P.W.3
-
9
-
-
0023374171
-
Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters
-
Morin, JE, Lubeck MD, Barton JE, et al: Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc Natl Acad Sci USA 84:4626-4630, 1987.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 4626-4630
-
-
Morin, J.E.1
Lubeck, M.D.2
Barton, J.E.3
-
10
-
-
0021248502
-
Infection of eucaryotic cells by helper-independent recombinant adenoviruses: Early region 1 is not obligatory for integration of viral DNA
-
Doren KV, Hanahan D, Gluzman Y: Infection of eucaryotic cells by helper-independent recombinant adenoviruses: Early region 1 is not obligatory for integration of viral DNA. J Virol 50:606-614, 1984.
-
(1984)
J Virol
, vol.50
, pp. 606-614
-
-
Doren, K.V.1
Hanahan, D.2
Gluzman, Y.3
-
11
-
-
0018377943
-
Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome
-
Mulligan RC, Howard BH, Berg P: Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome. Nature 277:108-114, 1979.
-
(1979)
Nature
, vol.277
, pp. 108-114
-
-
Mulligan, R.C.1
Howard, B.H.2
Berg, P.3
-
12
-
-
0018645296
-
SV40 recombinants carrying rabbit beta-globin coding sequences
-
Hamer DH, Smith KD, Boyer SH, et al: SV40 recombinants carrying rabbit beta-globin coding sequences. Cell 17:725-735, 1979.
-
(1979)
Cell
, vol.17
, pp. 725-735
-
-
Hamer, D.H.1
Smith, K.D.2
Boyer, S.H.3
-
13
-
-
0023068218
-
Methods for analyzing bovine papilloma virus-based calmodulin expression vectors
-
Rasmussen CD, Simmen RCM, MacDougall EA, et al: Methods for analyzing bovine papilloma virus-based calmodulin expression vectors. Methods Enzymol 139:642-654, 1987.
-
(1987)
Methods Enzymol
, vol.139
, pp. 642-654
-
-
Rasmussen, C.D.1
Simmen, R.C.M.2
MacDougall, E.A.3
-
14
-
-
2542537376
-
Construction of live vaccines using genetically engineered proxviruses: Biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein B
-
Paoletti E, Lipinskas BR, Samsonoff C, et al: Construction of live vaccines using genetically engineered proxviruses: Biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein B. Proc Natl Acad Sci USA 81:193-197, 1984.
-
(1984)
Proc Natl Acad Sci USA
, vol.81
, pp. 193-197
-
-
Paoletti, E.1
Lipinskas, B.R.2
Samsonoff, C.3
-
15
-
-
0023774642
-
A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes
-
Coupar BEH, Andrew ME, Boyle DB: A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. Gene 68:1-10, 1988.
-
(1988)
Gene
, vol.68
, pp. 1-10
-
-
Coupar, B.E.H.1
Andrew, M.E.2
Boyle, D.B.3
-
16
-
-
0023082153
-
Vaccinia virus expression vectors
-
Moss B, Flexner C: Vaccinia virus expression vectors. Annu Rev Immunol 5:305-324, 1987.
-
(1987)
Annu Rev Immunol
, vol.5
, pp. 305-324
-
-
Moss, B.1
Flexner, C.2
-
17
-
-
0000980541
-
Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras
-
Shih M-F, Arsenakis M, Tiollais P, et al: Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras. Proc Natl Acad Sci USA 81: 5867-5870, 1984.
-
(1984)
Proc Natl Acad Sci USA
, vol.81
, pp. 5867-5870
-
-
Shih, M.-F.1
Arsenakis, M.2
Tiollais, P.3
-
18
-
-
0023921690
-
Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells
-
Margolskee RF, Kavathas P, Berg P: Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells. Mol Cell Biol 8:2837-2847, 1988.
-
(1988)
Mol Cell Biol
, vol.8
, pp. 2837-2847
-
-
Margolskee, R.F.1
Kavathas, P.2
Berg, P.3
-
19
-
-
0015847039
-
A new technique for the assay of infectivity of human adenovirus 5 DNA
-
Graham FL, van der E AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467, 1973.
-
(1973)
Virology
, vol.52
, pp. 456-467
-
-
Graham, F.L.1
Van Der, E.A.J.2
-
20
-
-
0017647917
-
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells
-
Wigler M, Silverstein S, Lee L-S, et al: Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11:223-232, 1977.
-
(1977)
Cell
, vol.11
, pp. 223-232
-
-
Wigler, M.1
Silverstein, S.2
Lee, L.-S.3
-
21
-
-
0015325125
-
Infectivity of human adenovirus-1 DNA
-
Nicholson MO, McAllister RM: Infectivity of human adenovirus-1 DNA. Virology 48:14-21, 1972.
-
(1972)
Virology
, vol.48
, pp. 14-21
-
-
Nicholson, M.O.1
McAllister, R.M.2
-
22
-
-
0022245909
-
Translation of mRNA injected into Xenopus oocytes is specifically inhibited by antisense RNA
-
Harland R, Weintraub H: Translation of mRNA injected into Xenopus oocytes is specifically inhibited by antisense RNA. J Cell Biol 101:1094-1099, 1985.
-
(1985)
J Cell Biol
, vol.101
, pp. 1094-1099
-
-
Harland, R.1
Weintraub, H.2
-
23
-
-
0019191911
-
High efficiency transformation by direct microinjection of DNA into cultured mammalian cells
-
Capecchi MR: High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22:479-488, 1980.
-
(1980)
Cell
, vol.22
, pp. 479-488
-
-
Capecchi, M.R.1
-
24
-
-
0001444987
-
Enhancer-dependent expression of human k immune-globulin genes introduced into mouse pre-B lymphocytes by electroporation
-
Potter H, Weir L, Leder P: Enhancer-dependent expression of human k immune-globulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci USA 81: 7161-7165, 1984.
-
(1984)
Proc Natl Acad Sci USA
, vol.81
, pp. 7161-7165
-
-
Potter, H.1
Weir, L.2
Leder, P.3
-
25
-
-
0023463013
-
Transfer of mammalian cells with plasmid DNA by scrape loading and sonication loading
-
Fechheimer M, Boylan JF, Parker S, et al: Transfer of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci USA 84:8463-8467, 1987.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 8463-8467
-
-
Fechheimer, M.1
Boylan, J.F.2
Parker, S.3
-
26
-
-
0020321716
-
Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles
-
Okada CY, Rechsteiner M: Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell 29:33-41, 1982.
-
(1982)
Cell
, vol.29
, pp. 33-41
-
-
Okada, C.Y.1
Rechsteiner, M.2
-
27
-
-
0022441811
-
A single method for incorporating aequorin into mammalian cells
-
Borle AB, Freudenrich CC, Snowdowne KW: A single method for incorporating aequorin into mammalian cells. Am J Physiol 251:C 323-C326, 1986.
-
(1986)
Am J Physiol
, vol.251
-
-
Borle, A.B.1
Freudenrich, C.C.2
Snowdowne, K.W.3
-
28
-
-
0020442374
-
Liposome-mediated DNA transfer in eukaryotic cells: Dependence of the transfer efficiency upon the type of liposomes used and the host cell cycle stage
-
Nicolan C, Sene C: Liposome-mediated DNA transfer in eukaryotic cells: Dependence of the transfer efficiency upon the type of liposomes used and the host cell cycle stage. Biochim Biophys Acta 721:185-190, 1982.
-
(1982)
Biochim Biophys Acta
, vol.721
, pp. 185-190
-
-
Nicolan, C.1
Sene, C.2
-
29
-
-
0027737455
-
Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy
-
San H, Yang Z-Y, Pompili VJ, et al: Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum Gene Ther 4:781-788, 1993.
-
(1993)
Hum Gene Ther
, vol.4
, pp. 781-788
-
-
San, H.1
Yang, Z.-Y.2
Pompili, V.J.3
-
30
-
-
0021879568
-
An efficient method for introducing macromolecules into living cells
-
Doxsey SJ, Sambrook J, Helenius A, et al: An efficient method for introducing macromolecules into living cells. J Cell Biol 101:19-27, 1985.
-
(1985)
J Cell Biol
, vol.101
, pp. 19-27
-
-
Doxsey, S.J.1
Sambrook, J.2
Helenius, A.3
-
31
-
-
0016537789
-
Microinjection of thymidine kinase and bovine serum albumin into mammalian cells by fusion with red blood cells
-
Schlegel RA, Rechsteiner MC: Microinjection of thymidine kinase and bovine serum albumin into mammalian cells by fusion with red blood cells. Cell 5:371-379, 1975.
-
(1975)
Cell
, vol.5
, pp. 371-379
-
-
Schlegel, R.A.1
Rechsteiner, M.C.2
-
32
-
-
0023276694
-
Effect of internal viral sequences on the utility of retro viral vectors
-
Armentano D, Yu S-F, Kantoff PW, et al: Effect of internal viral sequences on the utility of retro viral vectors. J Virol 61:1647-1650, 1987.
-
(1987)
J Virol
, vol.61
, pp. 1647-1650
-
-
Armentano, D.1
Yu, S.-F.2
Kantoff, P.W.3
-
33
-
-
0023177629
-
Evidence that the packaging signal of Moloney leukemia virus extends into the gag region
-
Bender MA, Palmer TD, Gelinas RE, et al: Evidence that the packaging signal of Moloney leukemia virus extends into the gag region. J Virol 61:1639-1646, 1987.
-
(1987)
J Virol
, vol.61
, pp. 1639-1646
-
-
Bender, M.A.1
Palmer, T.D.2
Gelinas, R.E.3
-
34
-
-
0025279872
-
Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
-
Miller DG, Adam MA. Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239-4242, 1990.
-
(1990)
Mol Cell Biol
, vol.10
, pp. 4239-4242
-
-
Miller, D.G.1
Adam, M.A.2
Miller, A.D.3
-
35
-
-
0027281883
-
R -transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer
-
R -transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer. Hum Gene Ther 4:331-354, 1993.
-
(1993)
Hum Gene Ther
, vol.4
, pp. 331-354
-
-
O'Shaughnessy, J.A.1
Cowan, K.H.2
Wilson, W.3
-
36
-
-
0024988334
-
Gene transfer into humans - Immunotherapy of patients with advanced melanoma, using tumor-infilitrating lymphocytes modified by retroviral gene transduction
-
Rosenberg SA, Aebersold P, Cornetta K, et al: Gene transfer into humans - Immunotherapy of patients with advanced melanoma, using tumor-infilitrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323:570-578, 1990.
-
(1990)
N Engl J Med
, vol.323
, pp. 570-578
-
-
Rosenberg, S.A.1
Aebersold, P.2
Cornetta, K.3
-
37
-
-
0026734495
-
An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer
-
Rill DR, Moen RC, Buschle M, et al: An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood 79:2694-2700, 1992.
-
(1992)
Blood
, vol.79
, pp. 2694-2700
-
-
Rill, D.R.1
Moen, R.C.2
Buschle, M.3
-
38
-
-
0027443191
-
Gene marking to determine whether autologous marrow infusion restores long-term haemalopoiesis in cancer patients
-
Brenner MK, Rill Dr, Holladay MS: Gene marking to determine whether autologous marrow infusion restores long-term haemalopoiesis in cancer patients. Lancet 342:1134-1137, 1993.
-
(1993)
Lancet
, vol.342
, pp. 1134-1137
-
-
Brenner, M.K.1
Dr, R.2
Holladay, M.S.3
-
39
-
-
85041132416
-
Genetic marking shows the Ph* cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML
-
Deisseroth AB, Zu Z, Claxton D, et al: Genetic marking shows the Ph* cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068-3076, 1994.
-
(1994)
Blood
, vol.83
, pp. 3068-3076
-
-
Deisseroth, A.B.1
Zu, Z.2
Claxton, D.3
-
40
-
-
0027031420
-
Simultaneous use of two retroviral vectors in human gene marking trials: Feasibility and potential applications
-
Miller AR, Skotzko MJ, Rhoades K, et al: Simultaneous use of two retroviral vectors in human gene marking trials: Feasibility and potential applications. Hum Gene Ther 3:619-624, 1992.
-
(1992)
Hum Gene Ther
, vol.3
, pp. 619-624
-
-
Miller, A.R.1
Skotzko, M.J.2
Rhoades, K.3
-
41
-
-
0028589416
-
Experimental and clinical studies of cytokine gene-modified tumor cells
-
Tepper RI, Mule JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5:153-164, 1994.
-
(1994)
Hum Gene Ther
, vol.5
, pp. 153-164
-
-
Tepper, R.I.1
Mule, J.J.2
-
42
-
-
0026611412
-
Reduced tumorigenicity of fibrosarcomas which constilutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer
-
Douvdevani A, Huleihel M, Zoller M, et al: Reduced tumorigenicity of fibrosarcomas which constilutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer. Int J Cancer 51:822-830, 1992.
-
(1992)
Int J Cancer
, vol.51
, pp. 822-830
-
-
Douvdevani, A.1
Huleihel, M.2
Zoller, M.3
-
43
-
-
0027499587
-
Transfection of interleukin 2 gene into human melanoma cells augment cellular immune response
-
Uchiyama A, Hoon, DSB, Morisaki T, et al: Transfection of interleukin 2 gene into human melanoma cells augment cellular immune response. Cancer Res 53:949-952, 1993.
-
(1993)
Cancer Res
, vol.53
, pp. 949-952
-
-
Uchiyama, A.1
Hoon, D.S.B.2
Morisaki, T.3
-
44
-
-
0025000864
-
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity
-
Gansbacher B, Zier K, Daniels B, et al: Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172:1217-1224, 1990.
-
(1990)
J Exp Med
, vol.172
, pp. 1217-1224
-
-
Gansbacher, B.1
Zier, K.2
Daniels, B.3
-
45
-
-
0025228373
-
Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2
-
Bubenik J, Simova J, Jandlova T: Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2. Immunol Lett 23:287-292, 1990.
-
(1990)
Immunol Lett
, vol.23
, pp. 287-292
-
-
Bubenik, J.1
Simova, J.2
Jandlova, T.3
-
46
-
-
0026026646
-
Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA
-
Russell SJ, Eccles SA, Hemming CL, et al: Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA. Int J Cancer 47:244-251, 1991.
-
(1991)
Int J Cancer
, vol.47
, pp. 244-251
-
-
Russell, S.J.1
Eccles, S.A.2
Hemming, C.L.3
-
47
-
-
0026033391
-
Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo
-
Ley V, Langlade-Demoyen P, Kourilsky P, et al: Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo. Eur J Immunol 21:851-854, 1991.
-
(1991)
Eur J Immunol
, vol.21
, pp. 851-854
-
-
Ley, V.1
Langlade-Demoyen, P.2
Kourilsky, P.3
-
48
-
-
0025095664
-
Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
-
Fearon ER, Pardoll DM, Itaya T, et al: Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397-403, 1990.
-
(1990)
Cell
, vol.60
, pp. 397-403
-
-
Fearon, E.R.1
Pardoll, D.M.2
Itaya, T.3
-
49
-
-
0027262224
-
Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma: Tumor inhibition by IL-2 but not by tumor necrosis factor
-
Karp SE, Farber A, Salo JC, et al: Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma: Tumor inhibition by IL-2 but not by tumor necrosis factor. J Immunol 150:896-908, 1993.
-
(1993)
J Immunol
, vol.150
, pp. 896-908
-
-
Karp, S.E.1
Farber, A.2
Salo, J.C.3
-
50
-
-
0027203715
-
Treatment of glioma by engineered interleukin 4-secreting cells
-
Yu JS, Wei MX, Chiocca EA, et al: Treatment of glioma by engineered interleukin 4-secreting cells. Cancer Res 53:3125-3128, 1993.
-
(1993)
Cancer Res
, vol.53
, pp. 3125-3128
-
-
Yu, J.S.1
Wei, M.X.2
Chiocca, E.A.3
-
51
-
-
0025602333
-
Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to antitumor function of interleukin 4
-
Li W, Diamantstein T, Blankenstein T: Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to antitumor function of interleukin 4. Mol Immunol 27:1331-1337, 1990.
-
(1990)
Mol Immunol
, vol.27
, pp. 1331-1337
-
-
Li, W.1
Diamantstein, T.2
Blankenstein, T.3
-
52
-
-
0026331269
-
Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
-
Golumbek PT, Lasenby A, Levitsky H, et al. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254:713-716, 1991.
-
(1991)
Science
, vol.254
, pp. 713-716
-
-
Golumbek, P.T.1
Lasenby, A.2
Levitsky, H.3
-
53
-
-
0024502120
-
Murine interleukin-4 displays potent anti-tumor activity in vivo
-
Tepper RI, Pattengale PK, Leder P: Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57:503-512, 1989.
-
(1989)
Cell
, vol.57
, pp. 503-512
-
-
Tepper, R.I.1
Pattengale, P.K.2
Leder, P.3
-
54
-
-
0026705784
-
In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells
-
Sun WH, Kreisle RA, Phillips AW, et al: In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. Cancer Res 52:5412-5415, 1992.
-
(1992)
Cancer Res
, vol.52
, pp. 5412-5415
-
-
Sun, W.H.1
Kreisle, R.A.2
Phillips, A.W.3
-
55
-
-
0026452173
-
Fibrosarcoma cells transduced with the 1L-6 gene exhibit reduced tumorigenicity, increased immunogenicity and decreased metastatic potential
-
Mullen CA, Coale M, Levy AT, et al: Fibrosarcoma cells transduced with the 1L-6 gene exhibit reduced tumorigenicity, increased immunogenicity and decreased metastatic potential. Cancer Res 52:6020-6024, 1992.
-
(1992)
Cancer Res
, vol.52
, pp. 6020-6024
-
-
Mullen, C.A.1
Coale, M.2
Levy, A.T.3
-
56
-
-
0026772066
-
Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells
-
Porgador A, Tzehoval E, Katz A, et al: Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res 52:3679-3686, 1992.
-
(1992)
Cancer Res
, vol.52
, pp. 3679-3686
-
-
Porgador, A.1
Tzehoval, E.2
Katz, A.3
-
57
-
-
0025837199
-
Interleukin 7 induces CD4+ T cell-dependent tumor rejection
-
Hock H, Dorsch M, Diamantstein T, et al: Interleukin 7 induces CD4+ T cell-dependent tumor rejection. J Exp Med 174:1291-1298, 1991.
-
(1991)
J Exp Med
, vol.174
, pp. 1291-1298
-
-
Hock, H.1
Dorsch, M.2
Diamantstein, T.3
-
58
-
-
0026582225
-
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo
-
Aoki T, Tashiro K, Miyatake S, et al: Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Pro Natl Acad Sci USA 89:3850-3854, 1992.
-
(1992)
Pro Natl Acad Sci USA
, vol.89
, pp. 3850-3854
-
-
Aoki, T.1
Tashiro, K.2
Miyatake, S.3
-
59
-
-
0027407938
-
Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma
-
Hock H, Dorsch M, Kunzendorf U, et al: Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci USA 90:2774-2778, 1993.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 2774-2778
-
-
Hock, H.1
Dorsch, M.2
Kunzendorf, U.3
-
60
-
-
0025827591
-
Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy
-
Jicha DL, Mule JJ, Rosenberg SA: Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. J Exp Med 174: 1511-1515, 1991.
-
(1991)
J Exp Med
, vol.174
, pp. 1511-1515
-
-
Jicha, D.L.1
Mule, J.J.2
Rosenberg, S.A.3
-
61
-
-
0026710683
-
Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity
-
McBride WH, Thacker JD, Comora S, et al: Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res 52:3931-3937, 1992.
-
(1992)
Cancer Res
, vol.52
, pp. 3931-3937
-
-
McBride, W.H.1
Thacker, J.D.2
Comora, S.3
-
62
-
-
0027953555
-
Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo
-
Tahara H, Zeh HJ III, Storkus WJ, et al: Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 54:182-189, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 182-189
-
-
Tahara, H.1
Zeh III, H.J.2
Storkus, W.J.3
-
63
-
-
0025852249
-
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo
-
Colombo MP, Ferrari G, Stoppacciaro A, et al: Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med 173:889-897, 1991.
-
(1991)
J Exp Med
, vol.173
, pp. 889-897
-
-
Colombo, M.P.1
Ferrari, G.2
Stoppacciaro, A.3
-
64
-
-
0027163179
-
Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-Tcell cooperation and Tcell-produced interferon-gamma
-
Stoppacciaro A, Melani C, Parenza M, et al: Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-Tcell cooperation and Tcell-produced interferon-gamma. J Exp Med 178:151-161, 1993.
-
(1993)
J Exp Med
, vol.178
, pp. 151-161
-
-
Stoppacciaro, A.1
Melani, C.2
Parenza, M.3
-
65
-
-
0027309489
-
High efficiency gene transfer into primary human tumor explants without cell selection
-
Jaffee EM, Dranoff G, Cohen LK, et al: High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res 53:2221-2226, 1993.
-
(1993)
Cancer Res
, vol.53
, pp. 2221-2226
-
-
Jaffee, E.M.1
Dranoff, G.2
Cohen, L.K.3
-
66
-
-
0027538181
-
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
-
Dranoff G, Jaffee E, Lazenby A, et al: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543, 1993.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 3539-3543
-
-
Dranoff, G.1
Jaffee, E.2
Lazenby, A.3
-
67
-
-
0025875209
-
Long-term inhibition of tumor growth by tumor necrosis factor on the absence of cachexia or T-cell immunity
-
Teng MN, Park BH, Koeppen HKW, et al: Long-term inhibition of tumor growth by tumor necrosis factor on the absence of cachexia or T-cell immunity. Proc Natl Acad Sci USA 88:3535-3539, 1991.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 3535-3539
-
-
Teng, M.N.1
Park, B.H.2
Koeppen, H.K.W.3
-
68
-
-
0025806563
-
Murine tumor cells transduced with the gene for tumor necrosis factor-alpha: Evidence for paracrine immune effects of tumor necrosis factor against tumors
-
Asher AL, Mule JJ, Kasid A, et al: Murine tumor cells transduced with the gene for tumor necrosis factor-alpha: Evidence for paracrine immune effects of tumor necrosis factor against tumors. J Immunol 146:3227-3234, 1991.
-
(1991)
J Immunol
, vol.146
, pp. 3227-3234
-
-
Asher, A.L.1
Mule, J.J.2
Kasid, A.3
-
69
-
-
0025849163
-
Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer
-
Blankenstein T, Quin Z, Uberla K, et al: Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med 173:1047-1052, 1991.
-
(1991)
J Exp Med
, vol.173
, pp. 1047-1052
-
-
Blankenstein, T.1
Quin, Z.2
Uberla, K.3
-
70
-
-
0024326949
-
Exogenous expression of mouse Interferon gamma cDNA in mouse neuoblastoma C1300 cells results in reduced tumorigenicity by augmented antitumor immunity
-
Watanabe Y, Kuribayashi K, Miyatake S, et al: Exogenous expression of mouse Interferon gamma cDNA in mouse neuoblastoma C1300 cells results in reduced tumorigenicity by augmented antitumor immunity. Proc Natl Acad Sci USA 86:9456-9460, 1989.
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 9456-9460
-
-
Watanabe, Y.1
Kuribayashi, K.2
Miyatake, S.3
-
71
-
-
0025604195
-
Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and lasting antitumor immunity
-
Gansbacher B, Bannerji R, Brian D, et al: Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and lasting antitumor immunity. Cancer Res 50:7820-7825, 1990.
-
(1990)
Cancer Res
, vol.50
, pp. 7820-7825
-
-
Gansbacher, B.1
Bannerji, R.2
Brian, D.3
-
72
-
-
12044253575
-
1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: Antitumor therapy by means of interferon-producing cells
-
1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: Antitumor therapy by means of interferon-producing cells. Cancer Res 53:1107-1112, 1993.
-
(1993)
Cancer Res
, vol.53
, pp. 1107-1112
-
-
Ferrantini, M.1
Proietti, E.2
Santodonato, L.3
-
74
-
-
0027502562
-
Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells
-
Connor J, Bannerji R, Saito S, et al: Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells. J Exp Med 177:1127-1134, 1993.
-
(1993)
J Exp Med
, vol.177
, pp. 1127-1134
-
-
Connor, J.1
Bannerji, R.2
Saito, S.3
-
75
-
-
8944227078
-
Potential clinical efficacy and lack of toxicity of IL-2 gene therapy of advanced lung cancer patients
-
abstract
-
Tan Y, Wang W, Wang B, et al: Potential clinical efficacy and lack of toxicity of IL-2 gene therapy of advanced lung cancer patients. Proc Am Soc Clin Oncol 13:328,1994 (abstract).
-
(1994)
Proc Am Soc Clin Oncol
, vol.13
, pp. 328
-
-
Tan, Y.1
Wang, W.2
Wang, B.3
-
76
-
-
8544248308
-
Gene therapy of metastatic melanoma patients with IL-2 transfected melanoma cells
-
abstract
-
Osanto S, Brouwenstijn N, Vaessen N, et al: Gene therapy of metastatic melanoma patients with IL-2 transfected melanoma cells. Proc Am Soc Clin Oncol 13:293, 1994 (abstract).
-
(1994)
Proc Am Soc Clin Oncol
, vol.13
, pp. 293
-
-
Osanto, S.1
Brouwenstijn, N.2
Vaessen, N.3
-
77
-
-
0027392843
-
+ T cells by B7-transfected melanoma cells
-
+ T cells by B7-transfected melanoma cells. Science 259:368-370, 1993.
-
(1993)
Science
, vol.259
, pp. 368-370
-
-
Townsend, S.E.1
Allison, J.P.2
-
78
-
-
0027175221
-
+ cytotoxic T lymphocytes in the absence of exogenous help
-
+ cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 177:1791-1796, 1993.
-
(1993)
J Exp Med
, vol.177
, pp. 1791-1796
-
-
Harding, F.A.1
Allison, J.P.2
-
79
-
-
0027280569
-
Immunotherapy of malignancy by in vivo transfer into tumors
-
Plautz GE, Yang Z-Y, Wu B-Y, et al: Immunotherapy of malignancy by in vivo transfer into tumors. Proc Natl Acad Sci USA 90:4645-4649, 1993.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 4645-4649
-
-
Plautz, G.E.1
Yang, Z.-Y.2
Wu, B.-Y.3
-
80
-
-
0028170350
-
Immunotherapy for cancer by direct gene transfer into tumors
-
Nabel GJ, Chang AE, Nabel EG, et al: Immunotherapy for cancer by direct gene transfer into tumors. Hum Gene Ther 5:57-77, 1994
-
(1994)
Hum Gene Ther
, vol.5
, pp. 57-77
-
-
Nabel, G.J.1
Chang, A.E.2
Nabel, E.G.3
-
81
-
-
0026053099
-
Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides
-
Helene C: Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur J Cancer 27:1466-1471, 1991.
-
(1991)
Eur J Cancer
, vol.27
, pp. 1466-1471
-
-
Helene, C.1
-
82
-
-
0026975584
-
Selective anti-gene therapy for cancer: Principles and prospects
-
Cohen JS: Selective anti-gene therapy for cancer: Principles and prospects. Tohoku J Exp Med 168:351-359, 1992.
-
(1992)
Tohoku J Exp Med
, vol.168
, pp. 351-359
-
-
Cohen, J.S.1
-
83
-
-
0027104702
-
Antisense and antigene properties of peptide nucleic acids
-
Hanvey JC, Peffer NJ, Bisi JE, et al: Antisense and antigene properties of peptide nucleic acids. Science 258:1481-1485, 1992.
-
(1992)
Science
, vol.258
, pp. 1481-1485
-
-
Hanvey, J.C.1
Peffer, N.J.2
Bisi, J.E.3
-
84
-
-
0001520251
-
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA
-
Wickstrom EL, Bacon TA, Gonzalez A, et al: Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci USA 85:1028-1032, 1988.
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 1028-1032
-
-
Wickstrom, E.L.1
Bacon, T.A.2
Gonzalez, A.3
-
85
-
-
0026089494
-
Normal and leukemic hematopoietic cells manifest differential sensitivity in inhibitory effects of c-myb antisense oligonucleotides: An in vitro study relevant to bone marrow purging
-
Calabretta B, Sims RB, Valtieri M, et al: Normal and leukemic hematopoietic cells manifest differential sensitivity in inhibitory effects of c-myb antisense oligonucleotides: An in vitro study relevant to bone marrow purging. Proc Natl Acad Sci USA 88: 2351-2355, 1991.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 2351-2355
-
-
Calabretta, B.1
Sims, R.B.2
Valtieri, M.3
-
86
-
-
0013689545
-
Inhibition of c-myc oncogene expression with ac-myc antisense oligonucleotide and its effects on proliferation and drug sensitive and resistant human small cell lung cancer cells
-
abstract
-
Van Waardenburg RCAM, Prins J, Meijer C, et al: Inhibition of c-myc oncogene expression with ac-myc antisense oligonucleotide and its effects on proliferation and drug sensitive and resistant human small cell lung cancer cells. Proc Am Assoc Cancer Res 35:615, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 615
-
-
Van Waardenburg, R.C.A.M.1
Prins, J.2
Meijer, C.3
-
87
-
-
8944240872
-
Growth inhibition of human Burkitt's lymphoma cells by c-myc-antisense oligodeoxynucleotides in vitro
-
abstract
-
Joshi SS, Verbik DJ, Tomes DJ, et al: Growth inhibition of human Burkitt's lymphoma cells by c-myc-antisense oligodeoxynucleotides in vitro. Proc Am Assoc Cancer Res 35:617, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 617
-
-
Joshi, S.S.1
Verbik, D.J.2
Tomes, D.J.3
-
88
-
-
8944246362
-
Electroporation of lymphoma cells with c-myc antisense oligonucleotides: A model for bone marrow purging
-
abstract
-
Bergan RC, Kyle EL, Neckers LM: Electroporation of lymphoma cells with c-myc antisense oligonucleotides: A model for bone marrow purging. Proc Am Assoc Cancer Res 35:308, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 308
-
-
Bergan, R.C.1
Kyle, E.L.2
Neckers, L.M.3
-
89
-
-
0027070730
-
In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides
-
Ratajczak MZ, Kant JA, Luger SM, et al: In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 89:11823-11827, 1992.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 11823-11827
-
-
Ratajczak, M.Z.1
Kant, J.A.2
Luger, S.M.3
-
90
-
-
0026754351
-
Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides
-
Ratajczak MZ, Hijiya N, Catani L, et al: Acute- and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides. Blood 79:1956-1961, 1992.
-
(1992)
Blood
, vol.79
, pp. 1956-1961
-
-
Ratajczak, M.Z.1
Hijiya, N.2
Catani, L.3
-
91
-
-
0025883201
-
Selective inhibition of leukemia cell proliferation BCR-ABL antisense oligodeoxynucleotides
-
Szczylik C, Skorski T, Nicholaides NC, et al: Selective inhibition of leukemia cell proliferation BCR-ABL antisense oligodeoxynucleotides. Science 253:562-565, 1991.
-
(1991)
Science
, vol.253
, pp. 562-565
-
-
Szczylik, C.1
Skorski, T.2
Nicholaides, N.C.3
-
92
-
-
0027506794
-
BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines
-
BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines. Blood 81:502-509, 1993.
-
(1993)
Blood
, vol.81
, pp. 502-509
-
-
Martial, P.1
Lewalle, P.2
Taj, A.S.3
-
93
-
-
8944260439
-
Liposomal delivery of methylphosphonate antisense oligodeoxynucleotodes in chronic myelogenous leukemia
-
abstract
-
Tari A, Tucker S, Deisseroth A, et al: Liposomal delivery of methylphosphonate antisense oligodeoxynucleotodes in chronic myelogenous leukemia. Proc Am Assoc Cancer Res 35:308, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 308
-
-
Tari, A.1
Tucker, S.2
Deisseroth, A.3
-
94
-
-
0027183168
-
1-positive leukemia cells and BCR/ABL oncoprotein-associated transformed cells
-
1-positive leukemia cells and BCR/ABL oncoprotein-associated transformed cells. Leukemia Lymphoma 10:307-316, 1993.
-
(1993)
Leukemia Lymphoma
, vol.10
, pp. 307-316
-
-
Okabe, M.1
Kunieda, Y.2
Miyagishmia, T.3
-
95
-
-
0027507179
-
Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA
-
Trojan J, Johnson TR, Rubin SD, et al: Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 259:94-97, 1993.
-
(1993)
Science
, vol.259
, pp. 94-97
-
-
Trojan, J.1
Johnson, T.R.2
Rubin, S.D.3
-
96
-
-
8944246363
-
Proliferation of leiomyosarcoma cell lines is inhibited by antisense oligonucleotides directed against the insulin growth factor type I receptor
-
abstract
-
Hirschfeld S, Helman LJ: Proliferation of leiomyosarcoma cell lines is inhibited by antisense oligonucleotides directed against the insulin growth factor type I receptor. Proc Am Assoc Cancer Res 35:258, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 258
-
-
Hirschfeld, S.1
Helman, L.J.2
-
97
-
-
0025072241
-
Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells
-
Daaka Y, Wickstrom E: Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells. Oncogene Res 5:267-275, 1990.
-
(1990)
Oncogene Res
, vol.5
, pp. 267-275
-
-
Daaka, Y.1
Wickstrom, E.2
-
98
-
-
0024334922
-
Modulation of ras expression by anti-sense, nonionic deoxyoligonucleotide analogs
-
Brown D, Yu Z, Miller P, et al: Modulation of ras expression by anti-sense, nonionic deoxyoligonucleotide analogs. Oncogene Res 4:243-252, 1989.
-
(1989)
Oncogene Res
, vol.4
, pp. 243-252
-
-
Brown, D.1
Yu, Z.2
Miller, P.3
-
99
-
-
0025736802
-
Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation
-
Saison-Behmoaras T, Tocque B, et al: Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation. EMBO J 10:1111-1118, 1991.
-
(1991)
EMBO J
, vol.10
, pp. 1111-1118
-
-
Saison-Behmoaras, T.1
Tocque, B.2
-
100
-
-
0027759997
-
Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype
-
Zhang Y, Mukhopadhyay T, Donehower LA, et al: Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Hum Gene Ther 4:451-460, 1993.
-
(1993)
Hum Gene Ther
, vol.4
, pp. 451-460
-
-
Zhang, Y.1
Mukhopadhyay, T.2
Donehower, L.A.3
-
101
-
-
0025225307
-
Inhibition of murine monocyte proliferation by a colony-stimulating factor-1 antisense oligodeoxynucleotide: Evidence for automne regulation
-
Birchenall-Roberts MC, Ferrer C, Ferns D, et al: Inhibition of murine monocyte proliferation by a colony-stimulating factor-1 antisense oligodeoxynucleotide: Evidence for automne regulation. J Immunol 145:3290-3296, 1990.
-
(1990)
J Immunol
, vol.145
, pp. 3290-3296
-
-
Birchenall-Roberts, M.C.1
Ferrer, C.2
Ferns, D.3
-
102
-
-
0025292217
-
The role of the c-fms oncogene in the regulation of HL-60 cell differentiation
-
Wu J, Zhu J-Q, Han K-K, et al: The role of the c-fms oncogene in the regulation of HL-60 cell differentiation. Oncogene 5:873-877, 1990.
-
(1990)
Oncogene
, vol.5
, pp. 873-877
-
-
Wu, J.1
Zhu, J.-Q.2
Han, K.-K.3
-
103
-
-
0026062164
-
Characterization of an interleukin-6-mediated automne growth loop in the human multiple myeloma cell line, U266
-
Schwab G, Siegall CB, Aarden LA, et al: Characterization of an interleukin-6-mediated automne growth loop in the human multiple myeloma cell line, U266. Blood 77:587-593, 1991.
-
(1991)
Blood
, vol.77
, pp. 587-593
-
-
Schwab, G.1
Siegall, C.B.2
Aarden, L.A.3
-
104
-
-
0013689545
-
Growth inhibition of renal carcinoma cell lines by interleukin-6 antisense oligonucleotides: An internal autocrine loop
-
abstract
-
Blay J-Y, Bolon I, Alberti L, et al: Growth inhibition of renal carcinoma cell lines by interleukin-6 antisense oligonucleotides: An internal autocrine loop. Proc Am Assoc Cancer Res 35:615, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 615
-
-
Blay, J.-Y.1
Bolon, I.2
Alberti, L.3
-
105
-
-
0024817936
-
Proliberation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor
-
Becker D, Meier C, Herlyn M: Proliberation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J 8:3685-3691, 1989.
-
(1989)
EMBO J
, vol.8
, pp. 3685-3691
-
-
Becker, D.1
Meier, C.2
Herlyn, M.3
-
106
-
-
8944221676
-
Specific PTO-antisense oligonucleotide therapy in malignant glidmas - An vitro study
-
abstract
-
Wismeth C, Jager A, Brysch W, et al: Specific PTO-antisense oligonucleotide therapy in malignant glidmas - An vitro study. Proc Am Assoc Cancer Res 35:617, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 617
-
-
Wismeth, C.1
Jager, A.2
Brysch, W.3
-
107
-
-
8944239906
-
P120antisense-mediated inhibition of breast cancer cell growth
-
abstract
-
Dunn M, Fonagy A, Swiderski C: P120antisense-mediated inhibition of breast cancer cell growth. Proc Am Assoc Cancer Res 35:530, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 530
-
-
Dunn, M.1
Fonagy, A.2
Swiderski, C.3
-
108
-
-
8944219799
-
Apoptotic cell death in human tumor cells following treatment with P120 antisense oligonucleotide ISIS-3466
-
abstract
-
Busch RK, Valdez BC, Henning D, et al: Apoptotic cell death in human tumor cells following treatment with P120 antisense oligonucleotide ISIS-3466. Proc Am Assoc Cancer Res 35:308, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 308
-
-
Busch, R.K.1
Valdez, B.C.2
Henning, D.3
-
109
-
-
9844253582
-
Phosphorothioate antisense oligonucleotides to protein kinase C (PKC) alpha inhibit proliferation in rat C6 glioma
-
abstract
-
Dooley NP, Baltuch GH, Yong VW: Phosphorothioate antisense oligonucleotides to protein kinase C (PKC) alpha inhibit proliferation in rat C6 glioma. Proc Am Assoc Cancer Res 35:566, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 566
-
-
Dooley, N.P.1
Baltuch, G.H.2
Yong, V.W.3
-
111
-
-
8944247782
-
Amplification of AKT7 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
-
abstract
-
Cheng JQ, Ruggeri B, Allomare DA, et al: Amplification of AKT7 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Am Assoc Cancer Res 35:530, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 530
-
-
Cheng, J.Q.1
Ruggeri, B.2
Allomare, D.A.3
-
112
-
-
0028231586
-
Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene
-
Fujiwara T, Grimm EA, Mukhopadhyay T, et al: Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54: 2287-2291, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 2287-2291
-
-
Fujiwara, T.1
Grimm, E.A.2
Mukhopadhyay, T.3
-
113
-
-
8944262229
-
p53 antisense oligonucleotides inhibit growth of human tumor cell lines
-
abstract
-
Hirota Y, Akahane K, Horiuchi T: p53 antisense oligonucleotides inhibit growth of human tumor cell lines. Proc Am Assoc Cancer Res 35:609, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 609
-
-
Hirota, Y.1
Akahane, K.2
Horiuchi, T.3
-
114
-
-
2642707995
-
Combination gene therapy targeting MYC and P53 in endometrial cancer cell lines
-
abstract
-
Janicek M, Nguyen H, Sevin BU, et al: Combination gene therapy targeting MYC and P53 in endometrial cancer cell lines. Proc Am Soc Clin Oncol 13:122, 1994 (abstract).
-
(1994)
Proc Am Soc Clin Oncol
, vol.13
, pp. 122
-
-
Janicek, M.1
Nguyen, H.2
Sevin, B.U.3
-
115
-
-
8944222144
-
Retroviral gene transfer of anti-ras ribozyme into tumor cells with activated ras oncogene
-
abstract
-
Li M, Kramer R: Retroviral gene transfer of anti-ras ribozyme into tumor cells with activated ras oncogene. Proc Am Assoc Cancer Res 35:373, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 373
-
-
Li, M.1
Kramer, R.2
-
116
-
-
8944240410
-
Supression of malignant melanoma phenotype by anti-oncogene ribozymes
-
abstract
-
Ohta Y, Kijima H, Kashfian BI, et al: Supression of malignant melanoma phenotype by anti-oncogene ribozymes. Proc Am Assoc Cancer Res 35:308, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 308
-
-
Ohta, Y.1
Kijima, H.2
Kashfian, B.I.3
-
117
-
-
0027289099
-
Prospects of gene-directed therapy with antisense oligodeoxynucleotides
-
Calabretta B, Skorski T, Szczylik C, et al: Prospects of gene-directed therapy with antisense oligodeoxynucleotides. Cancer Treat Rev 19:169-179, 1993.
-
(1993)
Cancer Treat Rev
, vol.19
, pp. 169-179
-
-
Calabretta, B.1
Skorski, T.2
Szczylik, C.3
-
118
-
-
8044260786
-
Phase I trial of systemic administration of OL (1) p53 oligonucleotide in refractory acute myelogenous leukemia and advanced myelodysplastic syndrome
-
abstract
-
Bishop MR, Bayever E, Iversen PL, et al: Phase I trial of systemic administration of OL (1) p53 oligonucleotide in refractory acute myelogenous leukemia and advanced myelodysplastic syndrome. Blood 82(Suppl 1):443a, 1993 (abstract).
-
(1993)
Blood
, vol.82
, Issue.1 SUPPL.
-
-
Bishop, M.R.1
Bayever, E.2
Iversen, P.L.3
-
119
-
-
8944227077
-
Autologous bone marrow (ABM) treated ex-vivo with oligonucleotide OL (1) p53 for transplantation in acute myelogenous leukemia (AML)
-
abstract
-
Bishop MR, Tarantolo SR, Bayever E, et al: Autologous bone marrow (ABM) treated ex-vivo with oligonucleotide OL (1) p53 for transplantation in acute myelogenous leukemia (AML). Blood 13(Suppl 1):312, 1994 (abstract).
-
(1994)
Blood
, vol.13
, Issue.1 SUPPL.
, pp. 312
-
-
Bishop, M.R.1
Tarantolo, S.R.2
Bayever, E.3
-
120
-
-
0022485359
-
Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
-
Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 46:5276-5281, 1986.
-
(1986)
Cancer Res
, vol.46
, pp. 5276-5281
-
-
Moolten, F.L.1
-
121
-
-
0027531548
-
In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats
-
Ram Z, Culver KW, Walbridge S, et al: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53:83-88, 1993.
-
(1993)
Cancer Res
, vol.53
, pp. 83-88
-
-
Ram, Z.1
Culver, K.W.2
Walbridge, S.3
-
122
-
-
0025899005
-
Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene
-
Ezzeddine ZD, Martuza RL, Platika D, et al: Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol 3:608-614, 1991.
-
(1991)
New Biol
, vol.3
, pp. 608-614
-
-
Ezzeddine, Z.D.1
Martuza, R.L.2
Platika, D.3
-
123
-
-
0025241769
-
Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors
-
Moolten FL, Wells JM: Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297-300, 1990.
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 297-300
-
-
Moolten, F.L.1
Wells, J.M.2
-
124
-
-
0039205029
-
Targeting of an inducible toxic phenotype in animal cells
-
Borrelli E, Heyman R, Hsi M, et al: Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci USA 85:7572-7576, 1988.
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 7572-7576
-
-
Borrelli, E.1
Heyman, R.2
Hsi, M.3
-
125
-
-
0027787053
-
In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy
-
Bi WL, Parysek LM, Warnick R, et al: In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 4:725-731, 1993.
-
(1993)
Hum Gene Ther
, vol.4
, pp. 725-731
-
-
Bi, W.L.1
Parysek, L.M.2
Warnick, R.3
-
126
-
-
0026772206
-
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
-
Culver KW, Ram Z, Walbridge S, et al: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552, 1992.
-
(1992)
Science
, vol.256
, pp. 1550-1552
-
-
Culver, K.W.1
Ram, Z.2
Walbridge, S.3
-
127
-
-
0025780973
-
Selective elimination of recombinant genes in vivo with a suicide retroviral vector
-
Plautz G, Nabel EG, Nabel GJ: Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 3:709-715, 1991.
-
(1991)
New Biol
, vol.3
, pp. 709-715
-
-
Plautz, G.1
Nabel, E.G.2
Nabel, G.J.3
-
128
-
-
0026445469
-
Gene therapy on malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells
-
Takamiya Y, Short MP, Ezzeddine ZD, et al: Gene therapy on malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 33:493-503, 1992.
-
(1992)
J Neurosci Res
, vol.33
, pp. 493-503
-
-
Takamiya, Y.1
Short, M.P.2
Ezzeddine, Z.D.3
-
129
-
-
8944255197
-
Tumor cell specific expression of herpes simplex thymidine kinase gene promoted by MYC binding sequence
-
abstract
-
Sugaya S, Fujita K, Tanaka K: Tumor cell specific expression of herpes simplex thymidine kinase gene promoted by MYC binding sequence. Proc Am Assoc Cancer Res 35:376, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 376
-
-
Sugaya, S.1
Fujita, K.2
Tanaka, K.3
-
130
-
-
8944224574
-
Regression of experimental murine melanoma after in situ transduction of a suicide gene
-
abstract
-
Mouawad R, Soubrane CI, Salzmann JL, et al: Regression of experimental murine melanoma after in situ transduction of a suicide gene. Proc Am Assoc Cancer Res 35:210, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 210
-
-
Mouawad, R.1
Soubrane, C.I.2
Salzmann, J.L.3
-
131
-
-
8944238984
-
Creation of herpes thymidine kinase mutants for gene therapy
-
abstract
-
Loeb LA, Munir K, Black ME: Creation of herpes thymidine kinase mutants for gene therapy. Proc Am Assoc Cancer Res 35:375, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 375
-
-
Loeb, L.A.1
Munir, K.2
Black, M.E.3
-
132
-
-
8944255196
-
Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
-
abstract
-
Chen S-H, Shine HD, Goodman JC, et al: Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Am Assoc Cancer Res 35:420, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 420
-
-
Chen, S.-H.1
Shine, H.D.2
Goodman, J.C.3
-
133
-
-
8944241799
-
Approaches to enhance gene transfer therapy with herpes simplex virus thymidine kinase in cultured rat glioma cells
-
abstract
-
Shewach DS, Zerbe LK, Breakefield XO, et al: Approaches to enhance gene transfer therapy with herpes simplex virus thymidine kinase in cultured rat glioma cells. Proc Am Assoc Cancer Res 35:374, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 374
-
-
Shewach, D.S.1
Zerbe, L.K.2
Breakefield, X.O.3
-
134
-
-
8944222601
-
In vivo combination gene therapy with the herpes simplex thymidine kinase (HS-tk) and interleukin-2 (IL-2) genes for the treatment of ovarian cancer
-
abstract
-
Link CJ, Beecham E, McCann L, et al: In vivo combination gene therapy with the herpes simplex thymidine kinase (HS-tk) and interleukin-2 (IL-2) genes for the treatment of ovarian cancer. Proc Am Soc Clin Oncol 13:256, 1994 (abstract).
-
(1994)
Proc Am Soc Clin Oncol
, vol.13
, pp. 256
-
-
Link, C.J.1
Beecham, E.2
McCann, L.3
-
135
-
-
0026599586
-
Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system
-
Mullen CA, Kilstrup M, Blaese RM: Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc Natl Acad Sci USA 89:33-37, 1992.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 33-37
-
-
Mullen, C.A.1
Kilstrup, M.2
Blaese, R.M.3
-
136
-
-
0025969742
-
Mullidrug resistance: A pleiotropic response to cytotoxic drugs
-
Fairchild CR, Cowan KH: Mullidrug resistance: A pleiotropic response to cytotoxic drugs. Int J Radiat Oncol Bio Phys 20:361-367, 1991.
-
(1991)
Int J Radiat Oncol Bio Phys
, vol.20
, pp. 361-367
-
-
Fairchild, C.R.1
Cowan, K.H.2
-
138
-
-
0028117270
-
Drug resistance: Genotype versus phenotype - Thirty-Second G.H.A. Clowes Memorial Award Lecture
-
Biedler JL: Drug resistance: Genotype versus phenotype - Thirty-Second G.H.A. Clowes Memorial Award Lecture. Cancer Res 54:666-678, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 666-678
-
-
Biedler, J.L.1
-
139
-
-
0025267824
-
Multidrug resistance phenotype of human BRO melanoma cells transfecled with a wild-type human mdr1
-
Lincke CR, van der blick AM, Schuurhuis GJ, et al: Multidrug resistance phenotype of human BRO melanoma cells transfecled with a wild-type human mdr1. Cancer Res 50: 1779-1785, 1990.
-
(1990)
Cancer Res
, vol.50
, pp. 1779-1785
-
-
Lincke, C.R.1
Van Der Blick, A.M.2
Schuurhuis, G.J.3
-
140
-
-
8944238982
-
Retroviral mediated transfer of the human mdr1 gene into bone marrow cells
-
abstract
-
Nooter K, Boesen JJB, Van Beusechem VW, et al: Retroviral mediated transfer of the human mdr1 gene into bone marrow cells. Proc Am Assoc Cancer Res 35:373, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 373
-
-
Nooter, K.1
Boesen, J.J.B.2
Van Beusechem, V.W.3
-
142
-
-
8944229229
-
Novel retroviral vectors for transducing two therapeutic genes for gene therapy of human hematopoietic cells
-
abstract
-
Kane SE, Metz MZ, Matsumoto L, et al: Novel retroviral vectors for transducing two therapeutic genes for gene therapy of human hematopoietic cells. Proc Am Assoc Cancer Res 35:373, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 373
-
-
Kane, S.E.1
Metz, M.Z.2
Matsumoto, L.3
-
143
-
-
8944230696
-
Variable MDR1 transduclion efficiency in different mammalian cells. Proc Am
-
abstract
-
Aksentijevich I, Germann UA, Licht T, et al: Variable MDR1 transduclion efficiency in different mammalian cells. Proc Am Assoc Cancer Res 35:375, 1994 (abstract).
-
(1994)
Assoc Cancer Res
, vol.35
, pp. 375
-
-
Aksentijevich, I.1
Germann, U.A.2
Licht, T.3
-
144
-
-
8944224573
-
Gene-therapy animal model to evaluate the long term effect and the efficiency of using the multiple drug resistance gene retroviral vectors in conferring the chemoresistance phenotype upon early progenitor cells
-
abstract
-
Hanania EG, Fu S-Q, Hegewisch-Becker S, et al: Gene-therapy animal model to evaluate the long term effect and the efficiency of using the multiple drug resistance gene retroviral vectors in conferring the chemoresistance phenotype upon early progenitor cells. Proc Am Assoc Cancer Res 35:210, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 210
-
-
Hanania, E.G.1
Fu, S.-Q.2
Hegewisch-Becker, S.3
-
145
-
-
0026637623
-
Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1
-
Sorrentino BP, Brandt SJ, Bodine D, et al: Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99-103, 1992.
-
(1992)
Science
, vol.257
, pp. 99-103
-
-
Sorrentino, B.P.1
Brandt, S.J.2
Bodine, D.3
-
146
-
-
0027092342
-
Transfer and expression of the human multidrug resistance gene in mouse erythroleukemia cells
-
DelaFlor-Weiss E, Richardson C, Ward M, et al: Transfer and expression of the human multidrug resistance gene in mouse erythroleukemia cells. Blood 80:3106-3111, 1992.
-
(1992)
Blood
, vol.80
, pp. 3106-3111
-
-
Delaflor-Weiss, E.1
Richardson, C.2
Ward, M.3
-
147
-
-
8944241329
-
Confering multiple drug resistance by mdrI gene transfection increases susceptibility to irradiation and lipid peroxidation
-
abstract
-
Mazzanti R, Fantappie' O, Fabrizio P, et al: Confering multiple drug resistance by mdrI gene transfection increases susceptibility to irradiation and lipid peroxidation. Proc Am Assoc Cancer Res 35:10, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 10
-
-
Mazzanti, R.1
Fantappie', O.2
Fabrizio, P.3
-
148
-
-
8944243575
-
Retrovirus-mediated gene transfer of glutathione S-transferase confers resistance to alkylating agents
-
abstract
-
Greenbaum M, Letourneau S, Assar H, et al: Retrovirus-mediated gene transfer of glutathione S-transferase confers resistance to alkylating agents. Proc Am Assoc Cancer Res 35:373, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 373
-
-
Greenbaum, M.1
Letourneau, S.2
Assar, H.3
-
149
-
-
8944221674
-
Generation of MDR1 retroviral vectors which coexpress a second gene under the control of a single promoter
-
abstract
-
Sugimoto Y, Aksentijevich I, Aran JM, et al: Generation of MDR1 retroviral vectors which coexpress a second gene under the control of a single promoter. Proc Am Assoc Cancer Res 35:375, 1994 (abstract).
-
(1994)
Proc Am Assoc Cancer Res
, vol.35
, pp. 375
-
-
Sugimoto, Y.1
Aksentijevich, I.2
Aran, J.M.3
-
150
-
-
0028283265
-
Transfection with a bcl-2 expression vector protests transplanted bone marrow from chemotherapy-induced myelosuppression
-
Kondo S, Yin D, Morimura T, et al: Transfection with a bcl-2 expression vector protests transplanted bone marrow from chemotherapy-induced myelosuppression. Cancer Res 54:2928-2933, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 2928-2933
-
-
Kondo, S.1
Yin, D.2
Morimura, T.3
|